Phase 1 Metastatic Solid Cancer Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab

Advanced Solid CancerMetastatic Solid Cancer

Boehringer Ingelheim60 enrolled9 locationsNCT07607678

Recruiting

Phase 1

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Breast CancerColorectal, CancerOvarian Cancer+4 more

National Cancer Institute (NCI)210 enrolled1 locationNCT06253520